Michael Harris, Ph.D., is a Senior Principal Scientist at Regeneron, focusing on developing advanced cell therapies as part of the Regeneron Cell Medicines team since April 2024. Previously, Michael served as a Senior Scientist at 2seventy bio, where Michael led a next-generation T cell therapy pipeline program. Additional experience includes roles as Investigator and Senior Scientist at BoAn Boston LLC, and a Machine Learning Consultant for Amplion, enhancing precision medicine through data analysis. Michael has also contributed to LUMICKS as an Application Scientist, supported the NIH BEST program as a Writer/Editor, and held editorial positions with the Oxbridge Biotech Roundtable. An academic background includes a Ph.D. in Immunology from the University of Cambridge and a BSc in Genetics and Modern Language from The University of Manchester.
This person is not in any teams
This person is not in any offices